Clinical Trial Update: The Safety, Tolerability, PK and PD of GSK2339345 in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK2339345 in healthy subjects. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Drugs mentioned

• GSK2339345

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cough | Phase 1 | Status: COMPLETED